Is Vanadate Reduced by Thiols under Biological Conditions? Changing the Redox Potential of V(V)/V(IV) by Complexation in Aqueous Solution
- 1 April 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 49 (9), 4245-4256
- https://doi.org/10.1021/ic100080k
Abstract
Although dogma states that vanadate is readily reduced by glutathione, cysteine, and other thiols, there are several examples documenting that vanadium(V)−sulfur complexes can form and be observed. This conundrum has impacted life scientists for more than two decades. Investigation of this problem requires an understanding of both the complexes that form from vanadium(IV) and (V) and a representative thiol in aqueous solution. The reactions of vanadate and hydrated vanadyl cation with 2-mercaptoethanol have been investigated using multinuclear NMR, electron paramagnetic resonance (EPR), and UV−vis spectroscopy. Vanadate forms a stable complex of 2:2 stoichiometry with 2-mercaptoethanol at neutral and alkaline pH. In contrast, vanadate can oxidize 2-mercaptoethanol; this process is favored at low pH and high solute concentrations. The complex that forms between aqueous vanadium(IV) and 2-mercaptoethanol has a 1:2 stoichiometry and can be observed at high pH and high 2-mercaptoethanol concentration. The solution structures have been deduced based on coordination induced chemical shifts and speciation diagrams prepared. This work demonstrates that both vanadium(IV) and (V)-thiol complexes form and that redox chemistry also takes place. Whether reduction of vanadate takes place is governed by a combination of parameters: pH, solute- and vanadate-concentrations and the presence of other complexing ligands. On the basis of these results it is now possible to understand the distribution of vanadium in oxidation states (IV) and (V) in the presence of glutathione, cysteine, and other thiols and begin to evaluate the forms of the vanadium compounds that exert a particular biological effect including the insulin-enhancing agents, antiamoebic agents, and interactions with vanadium binding proteins.This publication has 100 references indexed in Scilit:
- Anti-diabetic effects of vanadium(III, IV, V)–chlorodipicolinate complexes in streptozotocin-induced diabetic ratsBioMetals, 2009
- Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activitiesJBIC Journal of Biological Inorganic Chemistry, 2009
- Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV)Journal of Inorganic Biochemistry, 2008
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- The systems VIVO2+-glutathione and related ligands: a potentiometric and spectroscopic studyJBIC Journal of Biological Inorganic Chemistry, 2002
- Orally Active and Long-Term Acting Insulin-Mimetic Vanadyl Complex: Bis(Picolinato)oxovanadium(IV)Biochemical and Biophysical Research Communications, 1995
- In vivo andin vitro studies of vanadate in human and rodent diabetes mellitusMolecular and Cellular Biochemistry, 1995
- Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agentsMolecular and Cellular Biochemistry, 1995
- Dioxomolybdenum(VI) Complexes Stabilized by Polydentate Ligands with NO3, N2O2, and NS2 Donor-Atom SetsInorganic Chemistry, 1994
- Aqueous Chemistry of Labile Oxovanadates: Relevance to Biological StudiesComments on Inorganic Chemistry, 1994